Straits Times Index
3,292.69 +10.64 (+0.32%) S&P 500
5,091.06 +55.37 (+1.10%) Dow
38,321.34 +505.42 (+1.34%) Nasdaq
15,904.29 +246.46 (+1.57%) Bitcoin USD
58,729.59 -1,599.65 (-2.65%) CMC Crypto 200
1,231.66 -107.41 (-8.04%)
PAVmed Inc. (PAVM)
| Previous close | 2.0000 |
| Open | 2.1500 |
| Bid | 0.0000 x 0 |
| Ask | 2.3200 x 100 |
| Day's range | 2.0100 - 2.3400 |
| 52-week range | 1.6000 - 9.0000 |
| Volume | |
| Avg. volume | 64,026 |
| Market cap | 21.28M |
| Beta (5Y monthly) | 0.83 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -9.1600 |
| Earnings date | 13 May 2024 - 17 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 10.75 |
PR NewswirePAVmed Subsidiary, Veris Health, Signs Memorandum of Understanding with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company") a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, and its majority-owned digital health subsidiary Veris Health Inc. ("Veris"), today announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (the "OSUCCC – James"), a National Cancer Institute-Designated Comprehensi
PR NewswireLucid Diagnostics Partners with the Esophageal Cancer Action Network (ECAN) to Highlight Esophageal Cancer Awareness Month
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM), is partnering with the Esophageal Cancer Action Network (ECAN) to highlight Esophageal Cancer Awareness Month. ECAN, a leading patient advocacy organization focused on increasing esophageal cancer education, advocacy, awareness, and research, was founded 15 years ago by Mindy Mintz Mordecai following the t
ZacksWhy PAVmed Inc. (PAVM) Dipped More Than Broader Market Today
PAVmed Inc. (PAVM) closed at $2.07 in the latest trading session, marking a -1.43% move from the prior day.
